|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss for the period | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock based compensation | |||||
| Borrowed inventory included in cost of sales | |||||
| Payment of deposit on borrowed inventory | |||||
| Net realizable value adjustments | |||||
| Amortization of mineral properties | |||||
| Depreciation of capital assets | |||||
| Accretion of asset retirement obligations | |||||
| Amortization of deferred loan costs | |||||
| Gain on loan forgiveness | |||||
| Amortization of debt discount | |||||
| Provision for reclamation | |||||
| Gain on sale of assets | |||||
| Mark to market loss (gain) | |||||
| Loss (gain) on sale of assets | |||||
| Unrealized foreign exchange gain | |||||
| Lease receivable | |||||
| Trade receivables | |||||
| Inventory | |||||
| Lease receivables | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and accrued liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing activities | |||||
| Purchase of capital assets | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities | |||||
| Issuance of common shares for cash | |||||
| Share issue costs | |||||
| Proceeds from convertible notes issuance | |||||
| Convertible notes financing costs | |||||
| Purchase of capped call | |||||
| Proceeds from exercise of warrants and stock options | |||||
| RSU redeemed for cash | |||||
| Changes in financial lease liability | |||||
| Repayment of long-term debt | |||||
| Net cash provided by (used in) financing activities | |||||
| Effects of foreign exchange rate changes on cash | |||||
| Increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents | |||||
| Beginning cash and cash equivalents, and restricted cash and cash equivalents | |||||
| Ending cash and cash equivalents, and restricted cash and cash equivalents | |||||
Loading...